PSMA PET-CT Scan

PROCEDURE2 trials

Sponsors

University of Washington, Jonsson Comprehensive Cancer Center

Conditions

Metastatic Castration-Resistant Prostate CarcinomaOligometastatic Prostate AdenocarcinomaRecurrent Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8

Phase 2

Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease

RecruitingNCT06526299

University of WashingtonMetastatic Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8

Start: 2025-04-29End: 2027-12-31Target: 51Updated: 2026-03-24

Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma

RecruitingNCT07150715

Jonsson Comprehensive Cancer CenterOligometastatic Prostate Adenocarcinoma, Recurrent Prostate Adenocarcinoma

Start: 2025-12-12End: 2031-10-31Target: 107Updated: 2025-12-17